Assigned to APPROP                                                                                                             FOR COMMITTEE

 


 

 

 


ARIZONA STATE SENATE

Fifty-Fourth Legislature, First Regular Session

 

FACT SHEET FOR S.B. 1532

 

appropriations; felony pretrial intervention programs

Purpose

            Appropriates monies from the state General Fund (GF) for felony pretrial intervention programs (FPIPs) and related costs.

Background

            Laws 2017, Chapter 286 appropriated $2,750,000 in FY 2018 to be distributed to county attorney offices in counties with a population of less than three million persons for administering FPIPs. The appropriated monies consist of $1,000,000 from the Penitentiary Land Fund, $1,000,000 from the State Charitable Land Fund and $750,000 from the Inmate Store Proceeds Fund. FPIPs are directed to provide substance abuse treatment to offenders who are nonrepetitive and nondangerous. Services include medically assisted treatment, mandatory drug testing when appropriate, cognitive behavioral therapy and case management services.

            An FPIP typically requires qualifying offenders to complete treatment while a criminal prosecution is suspended. If a defendant fails to successfully complete the FPIP requirements, then the prosecution will resume.

            S.B. 1532 appropriates $1,500,000 in FY 2020 and FY 2021 from the state GF.

Provisions

1.      Appropriates $750,000 from the state GF in FY 2020 and FY 2021 to the Yavapai County Sheriff's Office for administering FPIPs, probation surveillance and case management costs.

2.      Appropriates $750,000 from the state GF in FY 2020 and FY 2021 to an unspecified entity for purchasing and supporting a patient-engagement mobile application system.

3.      Requires the unspecified entity to distribute the monies to an Arizona Health Care Cost Containment System eligible drug treatment provider.

4.      Requires the patient-engagement mobile application system do all the following:

a)      comply with federal Health Insurance Portability and Accountability Act privacy standards;

b)      provide deoxyribonucleic acid matched urinalysis samples to monitor the mobile application user's substance use;

c)      provide technology for video service between the mobile application user and case manager or probation officer;

d)      be able to track the mobile application user in real time;

e)      allow the mobile application user access to a personalized treatment plan; and

f)       be able to integrate with the mobile application user's electronic health records.

5.      Exempts the appropriations from statutory requirements relating to lapsing.

6.      Becomes effective on the general effective date.

Prepared by Senate Research

February 15, 2019

LMM/kja